PTPI Petros Gross Profit Rate

Corporate emblem and logo of Petros (PTPI)

The gross margin level on the GURU.Markets terminal chart reflects current dynamics, where 0.00 becomes the new value for this metric. Quotes are subject to the influence of low-cost generics and the digitalization of medicine. Profitability relies on the sale of men's health products and the development of the OTC segment. The reputation of Petros Pharmaceuticals (PTPI) is based on ensuring privacy and the accessibility of proven therapy methods.

Gross Profitability: Petros Pharmaceuticals, Inc. (PTPI) for 07/04/2022 - 06/28/2025

Analytical breakdowns and data insights for company Petros (PTPI)

- share price and expert price forecast:
Manufactured products of Petros Pharmaceuticals Inc

This indicator reflects the difference between revenue and direct production costs, measuring the portion of profit available to cover operating expenses. High efficiency of this metric at Petros Pharmaceuticals (PTPI) depends directly on the qualifications of the recruited men's health experts and high-quality marketing. Analyzing the gross margin ratio on GURU.Markets allows investors to promptly identify any declines in business profitability.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|AMPH: Gross Profit Rate|Gross Profitability pacira.com (PCRX)|Gross Margin ARS Pharma (SPRY)|Theravance Biopharma - Return on Gross Profit|Gross Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Return on Gross Profit|Gross Profit Margin Tectonic Therapeutic|TNXP: Gross Margin|SXT China (SXTC) - Gross Margin|Gross Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Return on Sales by Gross Profit|Gross Profitability Invizyne (EXOZ)|ORMP - Gross Profit Margin|Gross Margin ENTX (Entera Bio)|Gross Sales Margin MindWalk Therapeutics|ABVC: Return on Gross Profit|CPIX - Gross Margin|QNTM (Quantum BioPharma) - Return on Gross Profit|Gross Profitability Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Gross Margin|Gross Margin ranitherapeutics.com|Gross Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Gross Return on Sales|lexariabioscience.com - Return on Gross Profit|Gross Margin Pulmatrix Inc PULM|Pheton Holdings - Gross Margin|Gross Profitability Margin APM|Lyra Therapeutics, Inc. (LYRA) - Gross Profitability|Gross Profit Margin Impact BioMedical, Inc. (IBO)|Gross Profitability TNF Pharma|YCBD: Gross Profit Rate|Gross Margin PRFX|CYTO - Gross Profit Margin|Gross Profitability Lipella LIPO|Gross Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Gross Profitability|Procaps (PROC) - Return on Gross Profit|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin